Our research focuses on evaluating and validating PET tracers for imaging the tumor microenvironment. We are especially interested in approaches for determining the level of radioresistance in solid tumors that affect radiotherapy treatment outcomes in cancer patients.

We combine PET technology with state-of-the-art technologies for molecular biology utilizing cell lines, tumor models, patient-derived samples, and clinical imaging of cancer patients. The research group is led by Adjunct Professor Tove Grönroos.

Read more: preclinical PET imaging